Sponsor or institution
Clinical trials and research at Stinginn, LLC
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $2.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Developing a vaccine to prevent diseases caused by the Human T Cell Lymphotropic Virus
This study is testing a new vaccine to help prevent and treat serious health issues linked to the HTLV-1 virus, like adult T cell leukemia and a nerve condition called HAM/TSP, and it's for people who might be at risk of getting this virus.
-
New treatments for cancer using human-specific STING activators
This study is looking at a new way to help your immune system fight cancer by using special drugs that can be taken by mouth, making it easier for patients to access treatment and potentially improve how well it works against different types of cancer.
-
Using STING activators to enhance cancer treatment
This study is looking at a new way to help your immune system fight aggressive leukemia by using a special treatment that activates a protein called STING, and it’s designed for patients whose leukemia has come back or hasn’t responded to other treatments.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.